Characterization of recombinant human growth differentiation factor-9 signaling in ovarian granulosa cells

Molecular and Cellular Endocrinology

Volumn 283, Issue 1-2, 2008, Pages 58-67

  Mottershead, David G ^a   Pulkki, Minna M ^a   Muggalla, Pranuthi ^a   Pasternack, Arja ^a   Tolonen, Minna ^a   Myllymaa, Samu ^a   Korchynskyi, Olexandr ^b   Nishi, Yoshihiro ^c   Yanase, Toshihiko ^c   Lun, Stan ^d   Juengel, Jennifer L ^d   Laitinen, Mika ^e   Ritvos, Olli ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c KYUSHU UNIVERSITY   (Japan)

^d AGRESEARCH   (New Zealand)

^e Biotechvisions Ltd   (Finland)

Author keywords

Granulosa cells; Growth differentiation factor 9 (GDF9); Human; Signaling pathway

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 9; SMAD3 PROTEIN; THYMIDINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; DRUG ACTIVITY; GRANULOSA CELL; HUMAN; HUMAN CELL; INFERTILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; FEMALE; GRANULOSA CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; RATS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SMAD PROTEINS; THYMIDINE; TRITIUM;

EID: 39149095952     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.11.007     Document Type: Article

References (38)

1. Bodin L., Di Pasquale E., Fabre S., Bontoux M., Monget P., Persani L., and Mulsant P. A novel mutation in the BMP15 gene causing defective protein secretion is associated with both increased ovulation rate and sterility in Lacaune sheep. Endocrinology (2006)
2. Bondestam J., Kaivo-oja N., Kallio J., Groome N., Hyden-Granskog C., Fujii M., Moustakas A., Jalanko A., ten Dijke P., and Ritvos O. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells. Mol. Cell Endocrinol. 195 1-2 (2002) 79-88
3. Carabatsos M.J., Elvin J., Matzuk M.M., and Albertini D.F. Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev. Biol. 204 2 (1998) 373-384
4. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., and Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17 11 (1998) 3091-3100
5. Dixit H., Rao L.K., Padmalatha V., Kanakavalli M., Deenadayal M., Gupta N., Chakravarty B., and Singh L. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause 12 6 (2005) 749-754
6. Dong J., Albertini D.F., Nishimori K., Kumar T.R., Lu N., and Matzuk M.M. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383 6600 (1996) 531-535
7. Dooley S., Hamzavi J., Breitkopf K., Wiercinska E., Said H.M., Lorenzen J., Ten Dijke P., and Gressner A.M. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125 1 (2003) 178-191
8. Elvin J.A., Yan C., Wang P., Nishimori K., and Matzuk M.M. Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol. Endocrinol. 13 6 (1999) 1018-1034
9. Eppig J.J. Oocyte control of ovarian follicular development and function in mammals. Reproduction 122 6 (2001) 829-838
10. Eramaa M., Heikinheimo K., Tuuri T., Hilden K., and Ritvos O. Inhibin/activin subunit mRNA expression in human granulosa-luteal cells. Mol. Cell Endocrinol. 92 2 (1993) R15-R20
11. Galloway S.M., McNatty K.P., Cambridge L.M., Laitinen M.P., Juengel J.L., Jokiranta T.S., McLaren R.J., Luiro K., Dodds K.G., Montgomery G.W., Beattie A.E., Davis G.H., and Ritvos O. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat. Genet. 25 3 (2000) 279-283
12. Gilchrist R.B., Ritter L.J., and Armstrong D.T. Mouse oocyte mitogenic activity is developmentally coordinated throughout folliculogenesis and meiotic maturation. Dev. Biol. 240 1 (2001) 289-298
13. Gilchrist R.B., Ritter L.J., and Armstrong D.T. Oocyte-somatic cell interactions during follicle development in mammals. Anim. Reprod. Sci. 82-83 (2004) 431-446
14. Gilchrist R.B., Ritter L.J., Cranfield M., Jeffery L.A., Amato F., Scott S.J., Myllymaa S., Kaivo-Oja N., Lankinen H., Mottershead D.G., Groome N.P., and Ritvos O. Immunoneutralization of growth differentiation factor 9 reveals it partially accounts for mouse oocyte mitogenic activity. Biol. Reprod. 71 3 (2004) 732-739
15. Gilchrist R.B., Ritter L.J., Myllymaa S., Kaivo-Oja N., Dragovic R.A., Hickey T.E., Ritvos O., and Mottershead D.G. Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation. J. Cell. Sci. 119 Pt 18 (2006) 3811-3821
16. Hanrahan J.P., Gregan S.M., Mulsant P., Mullen M., Davis G.H., Powell R., and Galloway S.M. Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol. Reprod. 70 4 (2004) 900-909
17. Hayashi M., McGee E.A., Min G., Klein C., Rose U.M., van Duin M., and Hsueh A.J. Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology 140 3 (1999) 1236-1244
18. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 95 5 (1998) 2509-2514
19. Hickey T.E., Marrocco D.L., Amato F., Ritter L.J., Norman R.J., Gilchrist R.B., and Armstrong D.T. Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells. Biol. Reprod. 73 4 (2005) 825-832
20. Hobbs S., Jitrapakdee S., and Wallace J.C. Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem. Biophys. Res. Commun. 252 2 (1998) 368-372
21. Juengel J.L., Hudson N.L., Heath D.A., Smith P., Reader K.L., Lawrence S.B., O'Connell A.R., Laitinen M.P., Cranfield M., Groome N.P., Ritvos O., and McNatty K.P. Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep. Biol. Reprod. 67 6 (2002) 1777-1789
22. Kaivo-Oja N., Bondestam J., Kamarainen M., Koskimies J., Vitt U., Cranfield M., Vuojolainen K., Kallio J.P., Olkkonen V.M., Hayashi M., Moustakas A., Groome N.P., ten Dijke P., Hsueh A.J., and Ritvos O. Growth differentiation factor-9 induces Smad2 activation and inhibin B production in cultured human granulosa-luteal cells. J. Clin. Endocrinol. Metab. 88 2 (2003) 755-762
23. Kaivo-Oja N., Mottershead D.G., Mazerbourg S., Myllymaa S., Duprat S., Gilchrist R.B., Groome N.P., Hsueh A.J., and Ritvos O. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells. J. Clin. Endocrinol. Metab. 90 1 (2005) 271-278
24. Korchynskyi O., and ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277 7 (2002) 4883-4891
25. Laissue P., Christin-Maitre S., Touraine P., Kuttenn F., Ritvos O., Aittomaki K., Bourcigaux N., Jacquesson L., Bouchard P., Frydman R., Dewailly D., Reyss A.C., Jeffery L., Bachelot A., Massin N., Fellous M., and Veitia R.A. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur. J. Endocrinol. 154 5 (2006) 739-744
26. Laitinen M., Vuojolainen K., Jaatinen R., Ketola I., Aaltonen J., Lehtonen E., Heikinheimo M., and Ritvos O. A novel growth differentiation factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse oocytes during folliculogenesis. Mech. Dev. 78 1-2 (1998) 135-140
27. Mazerbourg S., Klein C., Roh J., Kaivo-Oja N., Mottershead D.G., Korchynskyi O., Ritvos O., and Hsueh A.J. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mol. Endocrinol. 18 3 (2004) 653-665
28. McGrath S.A., Esquela A.F., and Lee S.J. Oocyte-specific expression of growth/differentiation factor-9. Mol. Endocrinol. 9 1 (1995) 131-136
29. McNatty K.P., Juengel J.L., Reader K.L., Lun S., Myllymaa S., Lawrence S.B., Western A., Meerasahib M.F., Mottershead D.G., Groome N.P., Ritvos O., and Laitinen M.P. Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function in ruminants. Reproduction 129 4 (2005) 481-487
30. McNatty K.P., Hudson N.L., Whiting L., Reader K.L., Lun S., Western A., Heath D.A., Smith P., Moore L.G., and Juengel J.L. The effects of immunizing sheep with different BMP15 or GDF9 peptide sequences on ovarian follicular activity and ovulation rate. Biol. Reprod. (2006)
31. McPherron A.C., and Lee S.J. GDF-3 and GDF-9: two new members of the transforming growth factor-beta superfamily containing a novel pattern of cysteines. J. Biol. Chem. 268 5 (1993) 3444-3449
32. Montgomery G.W., Zhao Z.Z., Marsh A.J., Mayne R., Treloar S.A., James M., Martin N.G., Boomsma D.I., and Duffy D.L. A deletion mutation in GDF9 in sisters with spontaneous DZ twins. Twin Res. 7 6 (2004) 548-555
33. Nishi Y., Yanase T., Mu Y., Oba K., Ichino I., Saito M., Nomura M., Mukasa C., Okabe T., Goto K., Takayanagi R., Kashimura Y., Haji M., and Nawata H. Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 142 1 (2001) 437-445
34. Palmer J.S., Zhao Z.Z., Hoekstra C., Hayward N.K., Webb P.M., Whiteman D.C., Martin N.G., Boomsma D.I., Duffy D.L., and Montgomery G.W. Novel variants in growth differentiation factor 9 in mothers of dizygotic twins. J. Clin. Endocrinol. Metab. 91 11 (2006) 4713-4716
35. Roh J.S., Bondestam J., Mazerbourg S., Kaivo-Oja N., Groome N., Ritvos O., and Hsueh A.J. Growth differentiation factor-9 stimulates inhibin production and activates Smad2 in cultured rat granulosa cells. Endocrinology 144 1 (2003) 172-178
36. Teixeira Filho F.L., Baracat E.C., Lee T.H., Suh C.S., Matsui M., Chang R.J., Shimasaki S., and Erickson G.F. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87 3 (2002) 1337-1344
37. Vitt U.A., Mazerbourg S., Klein C., and Hsueh A.J. Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9. Biol. Reprod. 67 2 (2002) 473-480
38. Wolfraim L.A., Alkemade G.M., Alex B., Sharpe S., Parks W.T., and Letterio J.J. Development and application of fully functional epitope-tagged forms of transforming growth factor-beta. J. Immunol. Methods 266 1-2 (2002) 7-18